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Endothelium-dependent relaxation of the aorta and coronary 
arteries is impaired in rabbits with expeximeotal athemsclem- 
sis iuduced by a cholesterol-rich diet (12). Coronary vascular 
reserve is also reduced in Watanabe be&able hyperiipidemic 
rabbii (3). Endotbeliimr-derived relaxing factor is nitric oxide 
or a nitroso compound that generates nitric oxide (45). There 
is considetable evidence that hypercholestemlemia and ath- 
eroselerosis are associated with incmased oxygen-derived free 
radid production, which is thought to degmde nitric oxide 
aud to account for deficiencies in endothelial-dependent relax- 
ation (6-8). Patbophysiologic concentrations of low density 
lipoprotein (LDL) may also inhibit endotheliumdependent 
relaxation (9). In humans, hypercholesterolemia impairs 
endotheliumdependent dilation of the coronary microcircula- 
ofcardiology, 
bfedide, 2-2 
IZedfs. Severity of myocardii iujury was siguiiruutly exacer- 
bated io cholesterol-fed robbits (752 f 4.& [mean + SE&f!) 
cofnpored witb that in aoa-cbolesteroi-fed rabbits (53.2 f 5.2%). 
This emerbation was prevented by treatment witb SNAP (50.2 f 
64%)butnotwltbGarginhte(70.5*6.0%)orN9ee(yipenirigaetiw 
(70d + 4.8%) iu cbotesterul-fed mbbi& Ikwwer, SNAF’ did uot timit 
infamttiblllon-w fedrobbits(60.8~4.2%).T%ero& 
premurepmductwassimikudmtugthecourseofthe~tin 
~~Pw 
Conclusions. Myocardial damage induced by iscbemia- 
reperfnsion was signiticantly exaeerbnted in rabbits fed a long- 
tenu choi&e11A4~#1 diet but was e&&vely reversed by tr&meut 
w&b a nitric oxide donor. However, tbis agent did not limit iuhct 
sizeiuuormairabbi~Tbus,auitricoxidedouorredoces 
myocardiil iafarct size iu atberowterotic but not in nouatJwro= 
sclerotic robbits 
(J Am COR c4udiol19%;27.?Jo)t-9) 
tion. This impairment can be corrected by short-term admm- 
i&ration of L-arginine (lo), a precursor of nitric oxide, or by the 
reductiou of serum cholesterol (11). Release of endothelium- 
derived relaxing factor in coronary arteries affected by isch- 
emia is substantially decreased after reperfusion, even in 
nonatherosclerotic animals (12-14), and this decrease may 
exacerbate the myocardial ischemia-reperfusion injury as a 
result of increased leukocyte and platelet aggregation as well 
as leukocyte adherence to the coronary em&helium, migra- 
tion into the extravascular space and plugging (1516). Admin- 
istration of nitric oxide donors or L-arginme can minimire the 
myocardial injury associated with &hernia-reperfusion 
(17,18). However, the role of nitric oxide in ischemia- 
reperfusiin injury is still controversial (1920). Few studies 
have shown an increased severity of acute myocardial ischemia 
in chronically atherosclerotic animals (21) although infarct 
size was not evahmted in that study. Acute hypercholesteml- 
emia also increases the severity of myocardial ischemia by a 
mechanism dependent on the noregow phenomenon (22-24). 
Recently, we reported that inhibition of nitric oxide synthesis 
exhibits the augmentation of myocardii infarct sire in rabbits 
(25). In this study, we compared tbe extent of myocardiai 
ischemia-reperfusion injury between chohxterol-fed and con- 
trol rabbits To iuvestigate diierences in the role of nitric oxide 
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in the propagation of myocardial injury between the two 
models, we also examined the effect of a stable nitric oxide 
donor (S-nitroso-N-acetylpnicillamine [SNM]) (26) or L- 
arginine on infarct size. These agents were administered 
immediately before coronary artery occlusion because a de- 
crease in nitric oxide synthesis may occur during ischemia- 
reperhtsion in experimentally atherosclerotic rabbits. 
Methods 
HousIng and feedIng Adult male Japanese white rabbits 
(n = 40) were fed a diet of standard laboratory food supple- 
mented with 1% cholesterol for 10 weeks. A second group of 
rabbits (n = 21) was fed standard laboratory food without 
added cholesterol. Water was available ad lib. All animals 
were housed under identical conditions (Niion Bioresearch, 
Inc., Hashima, Japan). Arterial blood samples anticoagu- 
lated with heparin (50 U/ml) were collected immediately 
before the lo-week feeding period and again at the end of 
the 10 weeks for the determination of plasma cholesterol 
concentration. 
Experimental protod. After 10 weeks on their respective 
diets, the rabbits were anesthetized with sodium pentobarbital 
injected into the marginal ear vein (30 mgkg), intubated and 
then ventilated with the use of a small animal respirator 
(model 683, Harvard Apparatus). The left femoral artery was 
used for the continuous measurement of arterial blood pres- 
sure with a pressure transducer (TP-3fMI’, Nihon Kohden, 
Tokyo, Japan) and heart rate, and the left femoral vein was 
used for drug administration and blood sampling. Lead II of 
the electrocardiogram (ECG) was monitored throughout the 
study. Hemodynamic variables w$re continuously recorded 
(model WT-645G recorder, Nihon Kohden). Left thoracotomy 
was performed and the heart was exposed. A silk thread was 
passed around a branch of the left circumgex coronary artery 
with a tapered needle, and the ends of the thread were passed 
through a smalI vinyl tube. The branch was occluded by pulling 
the snare, which was fixed by clamping the tube with a 
mosquito clamp. Ckchtsion of the coronary artery caused 
cyanosis and akinesis in the ischemic region and a marked ST 
segment increase on the ECG. After 30 min of coronary 
ochsion, the snare was r+ased; reperfusion was indicated by 
a change in color of the ventricular surface. The surgical 
wounds were repaired 30 min after reperf’usion, and the rabbits 
were returned to their cages for recovery. An aseptic surgical 
technique was observed throughout and benzy$enicillin 
(30,000 U/kg) was injected intramuscularly for infection pro- 
phylaxis. Forty-eight hours after operation, each rabbit was 
injected intravenously with loo0 IJ of heparin and adminis- 
tered an overdose of pentobarbital. lbe heart was then 
removed for postmortem analysii. 
The choksteroi-fed rabbits were divided into four groups 
treated with 1) SNAP (15 &kg body weight as a bolus 
plus 5 @kg/min). 2) karginine (30 mgkg as a bolus plus 
10 mg/kg/min), 3) a degradation product of SNAP, N- 
acetylpenicillamine (15 @kg as a bobs pb 5 &mm), or 
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4) vehicle (isotonic saline). The non-cholesterol-fed rabbik 
were treated with either SNAP or isotonic saline. SNAP, 
L-arginine, N-acetyipenicillamine and isotonic saline were in- 
fused into a femoral vein catheter with a syringe pump for 
60 min beginning immediately before coronary occlusion and 
ending 30 min after repexfusion. 
Ahho-ugh some investigators have administered a high dose 
of SNAPcontimmusIy (>lO @cg per min) (27,2g), such doses 
induced a significant decrease in systemic blood pressure. The 
dose of SNAP we used (5 &kg per min) also induced a slight 
decrease (-10%) in systemic blood pressure, but it had no 
significant effect on the rate-pressure prodilct in either the 
noncholesterol-fed or cholesterol-fed rabbits in a preliminary 
study. The dose of r-arginine (10 m&kg per min) used in our 
study is similar to that previously administered to hypercho- 
lesterolemic rabbits (29,30) and to that used in a myocardial 
ischemia-reperfusion model (31). Thii dose of L-arginine did 
not exert a significant et&t on the rate-pressure product in 
our previous study (25). The SNAP was obtained from Dojindo 
Laboratories (Kumamoto, Japan), L-arginine from Wako 
(Gsaka, Japan) and N-acetylpenicillamine from Sigma Chem- 
ical. 
M-t of it&ret sire. iieark were perfused with 
saline through the aorta to wash tiut residual blood. Evans blue 
dye (2%) was introduced after reocehtsion of the left coronary 
branch to estimate the area perfused by the occluded artery 
(isckmie region). The left ventricle was cut parallel to the 
apex base axis into six pieces, whii were then incubated with 
1% triphenyltetrazoIium chloride at 3PC for 10 min to stain 
the noninfarcted region. The ischemic, infarct and nonischemic 
regions were separated with scissors and weighed. The area at 
risk and infarct sire were defined as irchemic region/left 
ventricular and infarct region/ischemic region mass ratios, 
respectively, and were expressed as percentages, as previou@ 
descrii (3U3). 
Assesssneat of Ieokoqe oceomlllotial. Myeloperoxidasc 
activity was assess& by the method of Bradley et al. (34). but 
mod&d slightly, as descrii piously (35). Myocardial 
tissue was taken from the nonkhemic and kchemic regions of 
the heart, frozen rapidly in Iiquid nitrogen, pulverized and 
suspended in 50 mmoI/bter potiissiun; phosphate buffer (pH 
6.0). After centrifugation at 4O@lU X g for 15 min, the 
supmatant was assayed spectrophotometrically for myeloper- 
oxidaseactivi~,thechangeinabsorbanceat46Onmwas 
measured with dianisidine-hydrogen peroxide as the substrate. 
Gne unit of myeloperoxidase activity was defined as that 
capable of ciezading 1~1 peroxideknin at 30°C. Myocardial 
leukotriene 8, content was determined by the method of 
Fradin et al. (36). with slight moditkation. In brief. the 
myocardial tiaues suspended in 50 mmoI/Iiter potassium phos- 
phate buffer @H 6.0) were centrifuged at 3,000 X g for 5 min 
at 4°C and acetic acid was added to the supematants until a 
concentration of 0.1 mohIiter was reached. With a Bond Elut 
C2 colm~ (Varian) Ieukotriene B1 was extracted from the 
ocidikd supernatank with ethyl acetate. After the extract was 
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Table 1. Mortality Rate in Experimental Groups 
No. of Rabbits 
Ventricular Fibrillation 
Mortaliq 
Gmup occlusion Reperfusion Late Death’ Survived Rate (5%) 
Non-cbolesteml-fed 
rabbits 
vehicle (n = 12) 1 0 I 10 17 
SNAP (n = 9) 0 0 I 8 11 
Cholesterol-fed rabbits 
Vehicle (n = 13) 1 0 2 10 23 
SNAP (n = 10) I 0 1 8 20 
L-Arginiie (n = IO) I 0 2 7 30 
AP (n = 7) 1 0 1 5 28 
‘Death on the first postoperative day. No significant difference was seen in mortality among all six group. AP = 
N-acetylpeoicillamine; SNAP = S-nitroso-N-acetylpenicillamine. 
evaporated to dryness, the concentration of leukotriene B4 was Results 
determined with a specific enzyme immunoassay (Cayman). 
Masnremeat of attvmselwotie piaque area. The surface Mortality and characteristics. Five rabbits died of ventric- 
area of atherosclerotic lesions of the descending thoracic aorta ular fibrillation during coronary occhtsion and eight died on 
in cholesterol-fed rabbits was determined by removing the the first day after the operation, probably because of arrhyth- 
thoracic aorta from the left subclavian artery to the diaphragm. mia or heart failure. Although the mortality rates for the four 
Adventitial tissue was dissected free and the remaining blood groups of cholesterol-fed rabbits appeared higher than those 
was rinsed away. Each aorta was biied tongitudii and for the other two groups, the difference was not statistically 
hxed in 10% buffered formalin. The specimens were immersed signiticant (chi-square test) (Table 1). The 48 surviving rabbits 
in Sudan red stain at room temperature for 15 mitt and then were subjected to various analyses. The change in body mass 
transferred to t30% ethanol for 20 min. Measurements of lesion and the plasma total cholesterol concentration before the 
surface area and total aortic surface area were made by IO-week feeding period showed no significant differences 
planimetry of photographic images. among the six groups (Table 2). Among the four groups of 
Statlstkal analysis. Results are expressed as mean value + cholesterol-fed rabbits, there were no signihcant differences in 
SE Diierences in infarct size, myeloperoxidase activity, leu- the plasma concentration of total cholesterol and in the area of 
kotriene B4 content, atherosclerotic area of thoracic aorta atherosclerotic plaque of the thoracic aorta at 10 weeks. 
among groups and hemodynamic changes over time were Hemodpamic \ariautes. line systoric (Fig. IA) and dia- 
determined by analysis of variance. A p value < 0.05 was stolic (Fig. 1B) blood pressure after coronary occlusion in the 
considered signiticant. When multiple comparisons were per- hvo SNAP-treated groups was lower than that in the corre- 
formed, Tukey’s test was used to determine the p value spending vehicle-treated groups, but the differences were not 
required for statistical signiticance. Analysii of covariance was statistically significant. The heart rate (Fig. 1C) was slightly 
used to compare the regression lines between the area at risk higher in non-cholesterol-fed rabbits than in cholesterol-fed 
and infarct size among the groups. rabbits. However, the rate-pressure product, an index of 
Tat& 2. Characteristics of Experimental Groups (mean f SE) 
Total Plasma Area d 
Body Mas.9 (kg) Cholesterol (mgidl) Atbemsclerotic 
Grwp 
Plaque of Thoracic 
Before After Before After Aotta (‘X) 
Noa-cbokterol-fed rabbits 
vehicie (n = 10) 27 2 0.1 2.9 + O.l* 23k2 19I2 - 
SNAP (n = 8) 26 + 0.1 3.0 f 0.1’ 24 ? 3 21 + 3 
CbolesIeml-fed rabbits 
- 
vehicle (I) = IO) 27 k 0.1 2.9 + 0.1’ 2523 2.232 + 219t Il.1 r 2.0 
SNAP (tt = 8) 25 kO.1 3.0 % 0.1’ 2923 2220 2 2137 142 ?: 29 
L-m (n = 7) 2.6 f 0.1 29 ? 0.1’ 2622 1,880 + 154t 12.0 Z 3.2 
AP (a = 5) 26 + 0.1 29 + 0.1’ 2723 2,044’207t 10.6 2 2.5 
‘p < 0.05, tp < ODll wsta before ehoieaerol feeding Body mass and total plasma chcksteml cottcexmatiott were 
detemliwdhamediatelybeforeaadaftertbelOareekfeedingperiod. 
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Fm 1. Hemudynamic variables measured at base- 
line, immediately before reperfusiin and 30 min after 
reperfusion for cholesterol-fed (sotii symbols) and 
non-cholesterol-fed (open symbats) rabbits treated 
with vehicle (circles), S-nitroso&aeetylpeniciUamine 
(m) or L-arginiie (tria@s). Tbe rate-prwure 
product is systolii blood pressure multiplied by heart 
rate. Data are expressed as mean -C SE. Multiple 
comparisons of variables among the experimental 
groups were Performed by analysis of variance (Tukey’s 
test). Although the hemodynamic data for cholesterol- 
fed rabbits treated with A’-acetylpenicilIamine were not 
shown, there were nu significant differences in bemody- 
namic variables among all six groups. 
myocardiai oxygen consumption, was similar in all of the 
c. 
experimental groups (Fig. 1D). Although not shown, changes 
in the hemodynamic data in cholesterol-fed rabbits treated 
with N-acetylpenicillamine were not significantly different from 
the other live groups. 
Inhurt size. We expressed the area of the ischemic heart at 
risk and the amount of necrotic cardiac tissue as a percentage 
of the total left ventricular mass and of the area at risk, 
respectively. There were no significant ditferences in the area 
at risk (Fig. 2A). There were also no significant differences in 
the degree of !!iT segment elevation before reperfusiin and 
30 min after reperfusion among all six groups (data not 
shown). However, the infarct size w?s significantly higher (p < 
0.05) in vehicle-treated cholesterc!-fed rabbits (75.2 -C 4.4%) 
lhau in vehicA5treated non--en&fed rabbii (53.2 -t 
52%),indicatingthatthemj0caKMdamageinducedbyisch- 
emia-mperfnskm was signikmtly f2aacerhated in choieG~l-fed 
i&hits (F& 2B). The infarct size in non--ml-fed rabbits 
treatedwi*sNAp(~~~4%)didnot~~significao$fram 
thatinthecomqo&&vehidegroup.Ho5w5qtheinfarctsize 
incMesterol-fedrabbitstreatedwithSNAP(SO2?6.4%)was 
sign&antly(p~O.OS)smaJlerthanthatinthe~ 
vehictcgmupahholtghlherewasnosignificant~ererIoein 
inf2,rusizebetwm1tt1evehic&and~-arginine(705~6.~)or 
N-&IylpenicillanliDe (70.4 2 4.842) groups of cMesterol-fed 
rabbits. 
The absdute infarct size signilicantly correlated (p < 0.01) 
with the size of the area at risk in all groups: 1) non- 
cholesterol-fed: vehide. y = 0.90x - 0.69, r = 0.872: SNAP. 
y = 0.82x - 0.36, r = 0.90+ 2) cholesterol-fed: vehicle, y = 
1.09x - 0.66, r = 0.898: SNAP. y = 1.08x - 0.99, r = 0.898, 
r-arginine, f = 1.17x - 0.87. r = 0.93s; ~%acetylpenicillamine. 
v = 1.02x - 0.39, r = 0.962. Furthermore. the regression line 
ior the vehicle group of cholesterol-fed rabbits was signifkantly 
different (p < 0.05) from that for the vehicle groiip of 
non-cholesterol-fed rabbits and the SNAP group of cholester- 
&fed rabbits (Fig. 3). The regression lii did not dilTe7 
signilicantty between the two SNAP groups or between the 
vehicle and SNAP groups of non-cholesterol-fed rabbits 
These observations indicate that SNAP reduced the infarct size 
in the cholesterol-fed rabbits but nol in the non-cholesterol- 
fed rabbi& regardless of the size of the area at risk. 
LcstcKytc accumsslatlett. To determine the effects of 
SNAP on the acrumnladon of leukocytes into the izhemic 
myocardiua we examined myocardial myeloperoxidase activ- 
ity and leukotriene B, content in nonischemic and is&mic 
regions. Although myelq~~~xidase activity and kukofriene B, 
content in the nonischemic myotzdium did not vary among 
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Fit 2. Area at risk (A) and infarct size (B) for cholesterol-fed and 
non-cholesterol-fed rabbits treated with vehicle, S-nitroso-N- 
acetylpenicillamine (SNAP), L-arginine or N-acelylpenicillaminc (Ap). 
Data are expressed as mean value + SE. *p < 0.05 versus vehicle- 
treated non-cholesterol-fed rabbits. tp < 0.05 versus vehicle-treated 
ebnlesteroi-fed rabbits (analysis of variance with Scheffe test). 
the groups (data not shown), myeloperoxidase activity and 
teuk&rie~e &, content in the i&he&c myocardium if the 
vehicle and L-arginine groups of cholesterol-fed rabbits were 
significantly increased (p < 0.05) relative to the correspondiig 
values for the vehicle and SNAP groups of non-cholesterol- 
fed rabbits and the SNAP group of cholesterol-fed rabbits (Fig. 
4). 
Discussion 
Hyperei&sterolemia and nitric oxida In both humans 
and rabbits, coronary vascular reserve is markedly attenuated 
in the hypercholesterolemic state, posst%ly because increased 
oxygen-derived free radical production by the arterial wall 
results in degradation of nitric oxide (6-8); a decreased 
avaibhii of L-arginine to synthesize nitric oxide has been 
proposed in the coronary vasculature (29,30); or nitric oxide is 
inactivated by native and oxidized LDL acctmndated in the 
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Fwre 3. Linear regression analysis of the area at risk versus infarct 
size. A linear relation was apparent for each group. The regression line 
for the vehicle-treated group of cholesterol-fed rabbits (solid eireles) 
differed significantly from those for the vehicle-treated group of 
non-cholesterol-fed rabbits (open circles) and the S-nitroso-N- 
acetylpenicillamine-treated group of cholesterol-fed rabbits (solid 
squares). p < 0.05, analysis of covariance. 
vascular wall (37,38). An increase in the serum concentration 
of an endogenous inhibitor of nitric oxide synthesis has been 
demonstrated in hypercholesterolemic rabbits (39). In our 
preliminary study, we observed that the plasma NO,- plus 
NOz- concentration was significantly lower in our cholesterol- 
fed rabbits than in our non-cholesterol-fed rabbits, although 
constitutive nitric oxide synthase in aorta was more potently 
expressed in cholesterol-fed rabbits as assessed by immunohis- 
tochemistry. This finding supports the hypothesis that an 
impairment of endothelium-dependent vasodilation in athero- 
sclerotic vessels may not be due to a decrease in constitutive 
nitric oxide synthase expression (40). Measurement of hemo- 
dynamic variables revealed no difference in the sensitivity of 
the vascular bed to SNAP between normal and atherosclerotic 
rabbits, although Moncada et al. (41) demonstrated that 
removal of basal nitric oxide release results in increased 
supersensitivity of vascular tissue to nitrovasodilators. 
Nitric oxide in atheroscierotie rabbits. The increased se- 
verity of injury induced by acute myocardial &hernia in 
experimental atherosclerotic rabbits may result from the re- 
duction in nitric oxide synthesis or the increased inactivation of 
nitric oxide produced in the coronary circulation and conse- 
quent exacerbation of the no-reflow phenomenon. A decrease 
in the amounts of active nitric oxide augments leukocyte 
adherence to the endothelium of resistance vessels as well as 
aggregation of leukocytes and platelets. This sequence of 
events causes microcirculatory disorders of the ischemic coro- 
nary bed. Thromboxane A2 generation and platelet aggrega 
tion have been shown to be increased in the hypercholester- 
olemic state (42-45). Reactive oxygen species production (45) 
and vasoconstrictor effects of products from activated leuko- 
cytes (46) are known to be enhanced in hyperchol&terolemia. 
SNAP, by serving as a donor of nitric oxide, may inhiiit the 
aggregation of leukocytes and platelets as well as leukocyte 
adherence to the coronary endothelium provoked by reduction 
in active nitric oxide production (16-19, thus resulting in a 
decrease in leukocyte i&ration and limitation of infarct size 
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Fgmp 4. Myeloperoxidase (MO) activity (A) aad leakotriene B4 
(LTB,,) content (B) in the experimental groups. Vahws (mean -+ SE) 
represent levels in ischemic myocardium after subtraction of levels in 
nonisehemic myocardium. *p < 0.05 versus the vehicle-treated group 
of ncn-cholesteml-fed rabbits. Tp < 0.05 versus the vehicle-treated 
group of cholesteml-fed rabbits (analysis of variance with Scheffe test). 
SNAP = S-nitros+N-acctylpcnicillamirre. 
in cholesterol-fed rabbits. Our data on myeloperoxidase activ- 
ity and leukotriene B4 content in the myocardium support this 
conclusion. It is possble that nitric oxide is acting to scavenge 
superoxide anion, which is increased in both coronary arteries 
and myccardium in atherosclerotic animals (47), leading tc 
limitation of infarct sii. Because rabbits were used in our 
experiment owing to the extremely minimal native coronary 
collateral supply in this species (4t3), administration of SNAP is 
unlikely to reduce myocardial injury by increasing the extent of 
collateralixation. It is not clear why exogenous L-arginine did 
not exhiiit ,benetlcial effects similar to those of SNAP on 
infarct sixe in the atherosclerotic rabbits; exogenous L-arginine 
has been shown to normalixe the endotheliumdependent 
vasodilation in chronically hypercholesterolemic rabbits 
(293). However, our results are compatible with the notion 
that cholesterol feeding prevents incorporation of nitric oxide 
into a more potent nitrosylated compound or accelerates the 
intracellular or extracellular degmdation of endothelitms- 
derived relaxing factor (7,8,49). In an in vitro study, L-arginine 
proved to have no effect on improving endothelial dysfunction 
in atherosclerotic aorta (SO). 
Nitric oxide in mmathernsclerntic rabbits. Use of SNAP 
showed no effect on infarct size in non-cholesterol-fed rabbits. 
This cbservation appears inconsistent with those of previous 
studies showing that nitric oxide donors and L-arginine reduce 
myocardial ischemia-reperfusion injury (17,18). An incmasc in 
the endogenous production of nitric oxide during ischemia- 
reperbrsion may be enough to suppress the propagation of 
myocardial infarction in nonatherosclerotic rabbits. in fact, we 
recently reported that inhibition of nitric oxide synthesis by 
treatment with No-&o-r-arginine methyl ester exacerbates 
myocardial ischemia-reperfusion injury in rabbits (25). How- 
ever, excess amounts of exogenous nitric oxide added during 
ischemia-reperfusion may fail to limit infarct size further, 
possibly because interaction of nitric oxide with superoxide 
anion generates peroxynit+e and hydroxyl radical (51), which 
may be cytotoxic in excess. We also reported that treatment 
with L-arginine did not show an infarct-limiting effect in 
nonatherosclerotic rabbits (25). A similar observation has been 
descrii for the intestinal vascular injury apparent in the 
acute phase of cndotoxin shock: The ,physiologic formation of 
nitic oxide by constitutive nitti oxide synthase is important in 
protecting against tissue injury, but the inappropriate release 
of nitric oxide by the administration of high doses of SNAP can 
result in extensive tissue injury (52-54). Our results suggest a 
complex role for nitric oxide in protecting against myomrdial 
injury. ‘be effect of SNAP on infarct size may differ depending 
ontbedose,speciesandtimeofadmGtration.Wediinot 
examinetheeffectofalargerdoseofSNAPoninfarctsixe 
becausecontinuolsinfusionofsuchadoseofSNAP(lSIrg/kg 
per min) caused a signiticmt reduction in systemic blood 
prISSIKC. 
Sbdy limiWoa Esacerbatiou of my-dial injury in 
cholesterol-fed rabbits may he related to the presence of 
coronary artery stenosis In the four cholesterol-fed groups we 
found no diierence in the extent of area of atherosclerotic 
plaque of the thoracic aorta and no sign&ant stertotic lesions 
ofepican%alcoronaryartelies,althoughourevatuationof 
stenotic eoronaty artey lesiom was incomplete because of the 
measurement of infarct size. Osborne et al. (21) mported that 
there is a ccmsistent degree of stenosis in cholesterol-fed 
rabbits, comprising 50% to 75% of the conmary vessel 1-n 
of small arteries. However, the infarct sire even in rabbits with 
acute hypemholesterolemia (cholesterol fed for 4 days) was 
sigmticantly higter than that in control rabbits, and thii 
exacerbation was also prevented by treatment with SNAP 
(u+&shed o4xmatious). Because the effects of hypereho- 
lesterokmie on the vemek do not develop with very short-term 
hyperc~erolemia and coronary flow reserve deperm; 
mainly on nitric oxide production in resistance vesse& the 
s@&mceofstenoticcormuuyarteriestbemselvesinthe 
pmpagationofmpcanliatirjmymaybeso3lLNitrkoxide 
donorshavebeensbowntoattenuatethee6thelialdysfimc- 
tiotlobmvedirIreperfusedcoronaryarteriesoftlonathero- 
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y&r&z animals ex vivo (17,.5!). bzt it remains to be seen 
whether they can attenuate the endothelial dysfunction in 
those of atherosclerotic animals. It would be better to examine 
this issue in an in vivo state, although we cannot do these 
experiments in a rabbit model. Recently, Zweier ei al. (56) 
directly showed an increased production of nitric oxide in 
myocardial tissue during ixhemia, although we did not mea- 
sure nitric oxide production in the coronary circulation during 
ischemia-reperfusion. The possibility that SNAP is effective by 
another mechanism independent of nitric oxide release in 
protecting against myocardial injury in atherosclerotic rabbits 
cannot be excluded. 
Cnnelusiotts. We showed that 1) myocardial ischemia- 
reperfusion injury is exacerbated in rabbits fed a long term 
choksterol-rich diet compared with that in non-cholesterol- 
fed rabbits; 2) the augmentation of myocardial injury can be 
reversed by administration of the nitric oxide donor. SNAP. 
but not the nitric oxide precursor L-arginine: and 3) treatment 
with SNAP exerts no effect on infarct size in non-cholesterol- 
fed rabbits. In chronically hypercholesterolemic rabbits, the 
adequate amounts of nitric oxide endogenously produced 
during ischemia-reperfusion would be reduced, leading to 
propagation of myocardial infarction, although the excess 
amounts of nitric oxide may be deleterious in myocardial 
injury. In the clinical setting, active nitric oxide production in 
the coronary circulation of most patients who have undergone 
a myocardial infarction would be severely attenuated. similar 
to that in chronically cholesterol-fed rabbits. Although the 
atherosclerotic state in this experimental model is not the same 
as that in humans, one may need to examine the effect of an 
agent on limiting infarct size in chronically atherosclerotic 
animals before trying to test it in humans. Some agents may 
reduce myocardial infarct size in atherosclerotic but not in 
normal animals. 
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Koz& for secretarial assistance. 
References 
I. Jayakody L Settaratne M, Tltomsott A. Kappagoda T. Endothelium- 
dependent relaxation in expetintal atherosckro~b in the rabbit. Circ Res 
1987;6@2%64. 
2. Oshome JG Siegntan M. Sedar AW, Mooers SW. Lefer AM. Lack of 
endotheIium-depen&ent reianation ‘in coronav resistance arteries of 
cholesterol-fed rabbits. Am J Ph%ti 198a.256:C591-C597. 
3. Ciozd J-P. Lengsfehi H. Kahn ‘H. Baorngartner HR. Decrexsed coronan 
vasndar reserve in Watanabe heritable hv&iiihmk rabbits. Arteriorl~. 
JACC ~vi. ‘7. so. 4 
March 3. I‘%:~x)LY 
partial!\ restores endothelium-dep‘ndent u$cuhr rekwtionr in cholesterol- 
fed r&hits. Circ Rc, lWI:hY:1?93-IU)(I. 
7. Ohara Y. Peterson TE, Harrison DC. Hypercholesterolemia increws 
endothslial superoxide anion production. J Chn Invest 1993:91:?546-51. 
8 Ohata Y, Peterson TE. S;lvegh HS. Subramsnian RR. Wilcox JN. Harrison 
DG. Dietary correction of hypercholesterolemia in the r&it normalizes 
rndothelial wperoxide anion production. Circulation 199%9?:89X-903. 
9. Andrew HE. Bruckdorfer KR. Dunn RC, Ja&s M. Lowdensie lipopro. 
trim inhibit endot:,eliumdependent r&x&ion in rabbit :orta. Nature 
1987:27:237-Y 
IO. Dredrr H. Zxiher AM. Meiozer K. lust H. Correction of endothulial 
dytfuwtion in coronary microcirculation of hypercholaterolaemic patients 
hy I.- .r$inine. Lmcet 1991:338: r340-I.iSll. 
Il. Lcung W-H. Lw C-P. Wang C-K Ben&&d &ct of cholesterol-lowering 
therap) on coronary endothehumdepen&ot relawtion in h>prcholesterol- 
xmic patlent\. Lancet 1993:341:1496-15IIll 
12 Ku DD. Coronary wcular reacti\iv after acute myocardial ixhemia. 
Scitocc 1981::lY:i76-X. 
13. Van Budhuywn KM. McMurtry IF. Horwiu LD. Reperfosion after acute 
coronav occlusion in dogs imp& endothehumdependmt relaxation to 
acct$cholinr and augments contractile reacti+ in bitro. J Clin Imea 
19X7:79:lhj-74. 
14. Mehta IL. Nichols WW, Donnelly WH. Lauwn DL Saldsen TGP. Impaired 
canine mronar) xwdilator response to acetylcholine and bradykinin after 
ccchuon-reprrfusion Circ Re\ 1989:61:43-54. 
15. Ma X-L Weyrich AS. Lifer CJ. Lifer AM. Diminished bass! nitric oxide 
release after myocxdial iscxnia and repcrfusion promotes neutrophil 
adhereoxe to coronary mdo;&um. Circ Res 1993:7?:4l&IZ. 
16. Kurose 1. Wolf R. Grisham MB. &anger DN. Modulation of irhemia 
reperfwion-induced micro\a%dar &xfunction b, nitric “tide. Circ Rn 
1993:7J:376-X?. 
17. Siigfried MR Carey C. Ma X-L Izfrr AM. Beneficial etTects of SPM-5185. 
a +eine~oontaining NO donor in myocardial irhemia-reperfosion. Am J 
Physiol 1992:263H771-H777. 
18. Lefer DJ, Nakanishi K Johnston Vv’E. Vinten-Johanxn J. Antineutmphil 
and myocardial prote.:ing actions of a nael nitric oxide donor after 
myocardial irhemia and reperfusion in do@. Circulation IW3:88:233740. 
19. Ignarro U. Nitric oxide. A nowl sipal transduction mechanism for truw 
cellular communication. Hypertension 1’)90:16:177-83. 
20. Seekamp A. Mulligan MS. Till GO. Ward PA Requirements for neutrophil 
products and L-argmine in ischemia-repzrfosion injury. Am 1 Pathol 1993: 
l.l7:1?17-26. 
?I. Osborne IA. Mendey RK Lefer Ah#. Increased se\pri~ of xute myocardial 
ixhrmia in experimenul atherosclerosis. Heart Vesxk 1987:3:73-9. 
2. Golino P, Maroko PR Carew TE. The effect of acute hypercholesterolemia 
on mvocardial infarct six and the no-reflow phenomenon durine coroop~v 
occl&on-repetfusion. Circulation 1987:i?+--Y. 
- 
23. Golino P. Maroko PR. Carew TE. E@cxy of platelet depletion in coontrr- 
acting the detrimental effect of acute hypercholesterolemia on infarct stir 
and the no-reflow phenomenon in rabbits under@ng coronary arte~ 
occlusion-reperfosion. Circulation 1987376~17340. 
24. Ckhome IA. Lento PH. Siegfried MR Stahl CL Fusman B. Lefer A... 
Cardiiovaulrlx e&ctr of acute h~percholesterdemia in rabbits. RevenaI 
*ith lowtatin treatment. J Clin lovest 1959:83&S-73. 
5 Hoshida S, Yamashiu N. I-grashi J, et al. Nitric oxide synthax protects the 
heart against ischemia-reperfwion injo? in rabbits. J Phwnwol Exp Tber 
199?275:41%8. 
26. lgnarro LI, Lippon H. Edwards JC. et al. Mechanism of ocular smwth 
muscle relaxation by organic nitrates. nitrites. nitropmsside ;md nitric oxide: 
e+idence for the inrolvernent of S-nitrosothiols as active intermediates. 
J PhxroamI Em Ther 198l:?IH:739-49. . . . 
rosk 1988&310-20. 
4. Palmer RMJ, Ferrige AG. Mowada S. Nitric oride telex accounts for the 
biological activity of end&eliumdetied relaxing factor. Nature 1987327: 
524-6. 
5. Igm-10 Ll. Bym RE Buga GM. Wood KS. End&eliumderiwd relaxing 
fadorfmmpulmowyarteryandveinpows5espharmamlogieandchem- 
id properties identical to those of nitric oxidx radical Circ Res 1987$1: 
866-79. 
6. Mf& A EhveU nl. Petenon TE. H&eyes TG. He&d DD. I&rison 
ffi. cluonic Ireamteltl with p”ly&ylene-$y&ed supcroxide dismmse 
27. Boo&ton-Smith’ NK Hutcheson IR. De&in AM. WhittIe BJR Moncada S. 
Protective effect of S-nitrc5o%wetylprdcil~ine in endototin-induced 
qte intestinal damage in the rat. Eur J PharmacoI 199&lY1:4&8. 
28. Shaffer JE. Han B-J. Chem w Lee FW. Ixk of tolerance to a 24.hour 
infusion of S-nitmu, .V-acet&&ciIlatnine ISNAP) in cons&o5 rabbits. 
J Phamwol Exp Ther 199Z6IJ%6-93. 
29. Gierd XJ. Hi AT. Cooke JP. Dzio VJ. Creager .MA. L-Arginine 
augments endotheIiurndepertdent vawdilatioa in choksterol-fed r&hits. 
Cii Res 1990;67:1301-8. 
30. Cooke JP, Artdon NA Giird XJ. Hi AT. Crettger MA Argitt~# 
JACC Vol. 27. No. J 
March 15. 1996:0(12-Y 
restores cholinergic rrl;wtion of ~percholnterolrmic rabbit thoractc aorw 
Circulation 1991:8?J057-62. 
31. Wq7ieh h!i Ma X-L. Lefer AM. The role of L-argintne in ameliorating 
reperfmion injury afar m)wardiaJ isfhrmia in the cat. Circulation 1992% 
279-88. 
32. Kttzuva T. Hnshiia S. YamasJtita N. et al. De&d effects of subkthal 
ixhemia on the acouisition of tokrance tfi ishernia. Circ Rrs JU3.73: 
12939. 
33. Hoshida S. Kuzuya T. Yamashita N. et al. Gamma-glutatn$c@n ethyl 
ester for myocardii protection in dogs during irhemia and re~xrtitsion. 
J Am Coil C&ii 1594;2j:J391-7. 
W. Bradley PP. Priebat DA, Christenwt RD. R&stein G. Measurement of 
cutaneous i&mmation: estimation of netttrqhil content with an eqme 
marker. J Invest Demtatol 1982z785%-9. 
35. Hushida S, Kwya T. Niihida M. et al. Ebselen protects against irhemia- 
reperfusimt injuty in a canine model of myocardial infaroti. Am J Pbtid 
1994~7H2342-Hui7. 
36. Fradin A Zitrolli JA Maclottf J. Vattsbiider L. Henson PM. Mu& RC. 
Platelet-activating factor and Jettkmrieoe bioqtJx% in whole blood. A 
model for the study of tranwlJular arachidonate metab&m. J fmmund 
J98~1.l3:%EU-5. 
37. Jacobs M. Plane F. Brwkdorfer 1(R. Nathe and oxidiz& loudensit) 
lipopmteitts have different inhibitoF effects on endotheliumderived relax- 
ing factor in the rabbit aorta Br J Pharmxol 19%100-.?1-6. 
38. Galle J. Mulvh A Bus R Basenge E. Effects of natiw and oxidized Lou 
density lipoproteins on formaion and inactivation of EDRF. Artrria&r 
Tltromb 1991;11:19&203. 
39. Yu X-J. Li Y-J. Xiong Y. Increase of an en&gemws ;nhihitor of nitric oxide 
ymJtesis in sum of high cholesterol fed rabbits. Life Sci 1%51:753-S. 
40. JSirata K, Miki N. Km&Y. S.&da T. Kawshii 5. Yoke-ama M. Lm 
conceotratiat of oxidized lawdensity lipoprotein and ~wphc-@at@JcJe 
line upreplate amstitutiw nitric oxide ~nthase rnmA expression in baine 
aottk endothelial celk. Circ Rrs 199%76z958-61 
JI. Moncada S, Rees DD, Schulz R Palmer RMI. DewJopment and m&anism 
of a specific sttpersensitivity to nitrowcdilators after inhibition ot ocular 
nitric oxide syntJteris in tivo. Pmc Natl Acad Sci USA JW1:88:2166-70. 
42. Shattil SJ. Anaya-GaJindo R Bennett J. Colman RW. Cooper RA Platelet 
hypersensitivity induced by cholesterol incorporation. J Clio Jmest 197255: 
63643. 
43. Zmuda A Dembimka-Kiec .A ~kowki A Grvgkwki R1. Experimental 
atherosclerosis in rabbits: platelet aggregation. thrombaatte A, generation 
ukmia. ,4tknsckrti6 1990&3:iUJ-Y 
.s 
46. Hart JL Sobq CG. Wuodnun 0:. Chokwrol feed,,> cnhsnce\ \awc<,n- 
sttktor rffec& of pmdttcts from rat&t pol~morpJwnudedr Isuk~vss. Am J 
Pl&lJ995:26‘+.HJ-H6. 
47. Supari F. Lingerer T. Hart&m DG. Williams JK FsJt oil treatnwtt 
decreases superoxide anions in the m)cerdium and corortq dnmrrc, of 
atherosclerotic monk+. Circulation 199?9l:Jl~~~. 
lb. YawelI MP. Hearer DJ. Yellun D\4(. spCcic7 wri.ttun in the comnar) 
cirfulation during region.d mtccardiai t?rhemv: d mtal dewtntrunt of the 
rate of ewlution and etent uf m~wardmJ infarctton. Cardiewx Rr, 
19#‘-‘J:i37-16. 
49. Minor RL Jr. .%en PR Gtwra R Jr. Bates J%. Hatiwn DG DKt-iadwed 
atherovlermis imeasps the release of nitrogen ovida from r&it aorta. 
J CJk Imect 19!%%:3109-16. 
50. Miigge A Harriwn DG. t-.Argnine lheJ not retore rndothrlul ~~timctiott 
in atheroxkrotic r&it aorta In vitro. BJwd Vet, JWllx:351-7. 
51. &ckman JS. B&mart TW. Chat I. .WatiJl PA Frmman B.4. Apparsttt 
$dronl radial prcrrluction @ prrox)nitrits: impltittom ftx ettdotktial 
tnjuc frwn nitric oxide and supertide. Proc ?atl Acad Szi US.4 J!?%:d;: 
1620 4. 
52. Hutcham IR. M’hittJr BJR Bwghtoo-Stmth \K Rok of nitric &dc in 
mtintaininr rascttlar intqri~ m endotoxinxduccd acute intetinal damq 
in the rat. Br J Pharmaml I!?#kJlll:WJ.‘-3l. 
53. Wright CL Ren DD. Monada S. Protecthe ad p..ttholo&al role of nttric 
0th in codotti sJto& Cardioas Ret JW2?6:W-i?. 
54. Lop-klmoote 1. WJtittk BIR Monada 5. llw xwm of mtric ai& 
dooon in tlte prewntiun w indaion of mjur, to the rat @<tic rnirzsa. Br J 
Phamraml Jw3:Jll:7j-Y. 
